GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
GoodRx Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$3.37+0.01 (+0.30%)
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- 84.3
- Dividend yield
- –
GoodRx Holdings, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 90.8%
- Operating margin
- 9.5%
- Net margin
- 2.1%
- Return on equity, FY2025
- 4.5%
Financial strength
- Current ratio
- 1.38
- Debt to equity
- 0.75
- Debt to assets
- 20.8%
- Cash to current liabilities
- 25.6%
Valuation
- P/E ratio
- 84.3
- Price to sales
- 1.49
- Price to book
- 1.81
- Dividend yield
- –